-
Wonder Women Of Weed: Jodie Emery, The Entrepreneurial Rebel With A Cause
Tuesday, February 20, 2018 - 12:47pm | 1532"Wonder Women Of Weed" is a bi-monthly show and column featuring accomplished female leaders in the cannabis industry, brought from a collaborative effort that includes Benzinga, Industry Power Women and Direct Cannabis Network. This week, we’re presenting activist and...
-
Wonder Women Of Weed: Sara Gullickson, The Licensing Advisor Sitting At The Head Of The Boys' Table
Thursday, February 1, 2018 - 9:02am | 984Wonder Women Of Weed is a weekly column featuring accomplished female leaders in the cannabis industry. This week, we’re presenting Sara Gullickson, CEO and founder of DispensaryPermits.com, a national agency that has become one of the longest-standing firms in the...
-
Rodney And Holly Robinson Peete Talk About Hemp Cream For Pain Relief
Wednesday, September 27, 2017 - 9:19am | 863Dr. Randy Nordyke is the chairman and co-founder of InSpirit LLC. Inspirit produces two non-psychoactive — THC-free, 100 percent legal, over-the-counter pain relief crèmes made from organic hemp oil: Inspirit Hemp Crème and Inmotion Hemp Pain Crème. Over his life, Nordyke...
-
MassRoots CEO Explains Why 'Critics Are Missing The Point'
Tuesday, September 19, 2017 - 2:41pm | 1576Benzinga recently analyzed if MassRoots Inc (OTC: MSRT)'s acquisition of CannaRegs, Inc. for $12 million made sense. On one side of the spectrum was Alan Brochstein, author of the 420 Investor, who argued that the price tag was too high and that this could be seen as a proxy of MassRoots...
-
MassRoots And CannaRegs: Does The $12 Million Acquisition Make Sense?
Monday, September 11, 2017 - 8:56am | 1331Despite being one of the most notable companies in the cannabis industry, MassRoots Inc (OTC: MSRT) has not always been great at creating value for shareholders. As Alan Brochstein, author of the 420 Investor, told Benzinga late last year, the company “endured a perfect storm of sorts ......
-
What Zynerba's Flop Means For CBD Therapies And GW Pharmaceuticals
Monday, August 7, 2017 - 9:41am | 475Shares of Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) lost more than 58 percent of their value Monday morning after the company reported disappointing results from its phase 2 STAR 1 clinical trial for its adult epilepsy treatment. Zynerba is one of the largest cannabinoid-focused pharmaceutical...
-
High Times Will Go Public On The Nasdaq This Fall
Thursday, July 27, 2017 - 10:38am | 511Cannabis publication High Times will go public this fall and start trading on the Nasdaq exchange in October. When contacted by Benzinga, High Times' media team clarified that this is "not an IPO." According to a press release, Hightimes Holding Corp., the magazine’s publisher,...
-
Marijuana Venture Capitalist On CanopyBoulder's Investments: We Focus On Co's That Can Scale To Spectacular Levels Very Quickly
Tuesday, June 27, 2017 - 12:36pm | 1263"How does one start a business in the cannabis industry? What are the biggest hurdles to overcome?" —Benzinga In a recent conversation with Benzinga, Andy Williams — co-star of MSNBC's “The Pot Barons of Colorado” and founder and CEO of Medicine Man Denver, Medicine Man...
-
Maricann CEO Talks C$42.5M Financing Round And German Expansion: 'We Are In A Pole Position'
Wednesday, June 14, 2017 - 12:26pm | 645Last month, Maricann Group Inc. (CSE:MARI), a vertically integrated medical marijuana producer and distributor, announced it had secured C$42.5 million, or $32.2 million, in non-dilutive financing to increase production in Germany. This raise was one of the biggest of 2017 and Benzinga reached out...
-
This Biometric ID System Allows You To Buy Weed, Booze And Other Controlled Products From A Vending Machine
Saturday, June 10, 2017 - 12:38pm | 848American Green Inc (OTC: ERBB) recently unveiled a new system that allows vending machines to sell controlled and age-restricted products like alcohol, pharmaceuticals, casino chips, cannabis and even firearms. The system uses state-of-the-art biometric verification technology to...
-
The 420 Investor On MedReleaf's Rough IPO: The Stock Is Still A 'Screaming Buy'
Thursday, June 8, 2017 - 11:41am | 650MedReleaf Corp (TSE:LEAF), one of the major licensed cannabis producers in Canada, started trading on the TSX on Wednesday and its debut was far from pleasant. After opening at C$9.50 ($7.04), shares lost 22 percent, closing at C$7.40 ($5.48). According to Bloomberg data, this drop marked "the...
-
'Get Lit': Blend's Data Reveals How Millennials Talk About Weed
Saturday, May 27, 2017 - 7:03pm | 598Meet Blend Blend is a group-messaging app with a focus on content. By adding bots into its chat interface, the company is looking to tap into the “AI revolution,” joining tech giants of the likes of Apple Inc. (NASDAQ: AAPL), Snap Inc (NYSE: SNAP) and Facebook Inc (NASDAQ: FB). The...
-
Cannabinoid-Based Therapeutics Company Nemus Just Received $20 Million To Develop Its Drugs
Saturday, May 13, 2017 - 9:05pm | 1400The size of investments in the cannabis industry is rising at an unprecedented level, as evidenced by the more than $730 million raised by marijuana businesses in the four months of the year — versus $124 million in the first four months of 2016. One of the companies reaping the benefits of...
-
Weed Vs. Opioids: Nontraditional And Traditional Biotech Take On Wall Street, But Who's Winning?
Sunday, April 30, 2017 - 12:38pm | 1060As an increasing number of U.S. states legalize cannabis in one form or another and start to reap the economic and societal benefits of revised policies, support for marijuana legalization among the population (and even among police agents) continues to surge. On the other hand, as the opioid...